Literature DB >> 24528542

Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later.

C Bethan Powell1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24528542     DOI: 10.1016/j.ygyno.2014.01.018

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  8 in total

1.  Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.

Authors:  Britton Trabert; Sally B Coburn; Andrea Mariani; Hannah P Yang; Philip S Rosenberg; Gretchen L Gierach; Nicolas Wentzensen; Kathy A Cronin; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

2.  Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.

Authors:  Goli Samimi; Britton Trabert; Máire A Duggan; Jennifer L Robinson; Kisha I Coa; Elizabeth Waibel; Edna Garcia; Lori M Minasian; Mark E Sherman
Journal:  Gynecol Oncol       Date:  2018-03       Impact factor: 5.482

3.  Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK.

Authors:  Dhivya Chandrasekaran; Usha Menon; Gareth Evans; Robin Crawford; Ertan Saridogan; Chris Jacobs; Marc Tischkowitz; Elly Brockbank; Jatinder Kalsi; Davor Jurkovic; Ranjit Manchanda
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

Review 4.  Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation.

Authors:  Nicole Lugo Santiago; Evan Smith; Mary Cox; Carrie S Wan; Nana E Tchabo; Ibraheem Awowole; Vance Broach; Dennis S Chi
Journal:  Obstet Gynecol       Date:  2020-06       Impact factor: 7.623

5.  Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.

Authors:  Shandong Wu; Susan P Weinstein; Michael J DeLeo; Emily F Conant; Jinbo Chen; Susan M Domchek; Despina Kontos
Journal:  Breast Cancer Res       Date:  2015-05-19       Impact factor: 6.466

6.  Ovarian Cancer Previvors: How to manage these patients?

Authors:  Jesus Paula Carvalho; Edmund Chada Baracat; Filomena Marino Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2019-07-22       Impact factor: 2.365

Review 7.  Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2.

Authors:  David Samuel; Alexandra Diaz-Barbe; Andre Pinto; Matthew Schlumbrecht; Sophia George
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

Review 8.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.